𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preventing hepatitis C virus recurrence in liver transplant recipients: A role for adoptive immunotherapy?

✍ Scribed by Jean-Michel Pawlotsky; Stéphane Chevaliez

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
123 KB
Volume
51
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B virus cellular immunity afte
Hepatitis B virus cellular immunity after liver transplantation: A role in preventing hepatitis B virus recurrence?
✍ Anne Marie Roque-Afonso 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Chronic hepatitis B virus (HBV) infection is a common cause of advanced liver disease and hepatocellular carcinoma and has become a worldwide public health issue. Liver transplantation (LT) is the most effective therapeutic option for HBV-infected patients who have acute or chronic liver failure and

Anemia in liver transplant recipients un
Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C
✍ Sammy Saab; Mina K. Oh; Ayman B. Ibrahim; Francisco Durazo; Steven Han; Hasan Ye 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

Adherence to antiviral therapy is essential to achieve sustained virological responses in patients treated for hepatitis C. An important limitation to use of appropriate doses of ribavirin is development of anemia. The aim of this study is to identify risk factors associated with anemia in liver tra

The natural history of hepatitis C virus
The natural history of hepatitis C virus in pediatric liver transplant recipients
✍ Neal R. Barshes; Ian W. Udell; Timothy C. Lee; Christine A. O'Mahony; Saul J. Ka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Although rare in the pediatric population, the natural history of hepatitis C virus (HCV) recurrence in pediatric patients undergoing orthotopic liver transplantation (OLT) for end-stage liver disease secondary to HCV has not been well described. We performed an analysis of all 67 pediatric patients

Hepatitis G virus co-infection does not
Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients
✍ S J Cotler; D R Gretch; M P Bronner; H Tateyama; M J Emond; C dela Rosa; J D Per 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

The clinical significance of HGV infection is uncertain. ## Although hepatitis G virus infection (HGV) is usually Hepatitis G viremia has been documented in patients with asymptomatic, it has been associated with mild hepatic injury. acute hepatitis 1,6,7 and can persist for years, 1,5-7 althoug

Impact of tacrolimus versus cyclosporine
Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: A prospective, randomized trial
✍ Paul Martin; Ronald W. Busuttil; Robert M. Goldstein; Jeffrey S. Crippin; Goran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Hepatitis C virus (HCV)-induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a p

Prospective validation of a noninvasive
Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus–infected liver transplant recipients
✍ Salvador Benlloch; Laura Heredia; Claudia Barquero; José-Miguel Rayón; Ramón Pin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

We previously developed a mathematical model, the Hospital Universitario La Fe (HULF) index, as an alternative to protocol liver biopsy (PLB) to estimate significant fibrosis (SF) in patients who underwent liver transplantation (LT) for liver damage caused by chronic HCV infection. In the present st